$CYTR My checklist : 1) Do you like the science? 2) Do you like the science? 3) do you like the science? 4) Is the potential market size significant enough? 5) How does the intellectural property look? Patent issues?This is my weakness and it bothers me. 6) Share structure, future dilution. No problem here. Zero issues. 7) Other competition. IMO both or our drugs are in great shape there. 8) I should have made this more higher, maybe most important. Am I getting in too early? Major fuck up for me but how do you know? White wine nite.
  • 5